Evaluating the Clinical Impact of a Genomic Classifier in Prostate Cancer Using Individualized Decision Analysis

• Jennifer Mason Lobo ,

  * E-mail: jem4yb@virginia.edu

  Affiliation Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, United States of America

  ⨯
• Adam P. Dicker,

  Affiliation Department of Radiation Oncology, Jefferson Medical College and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States of America

  ⨯
• Christine Buerki,

  Affiliation GenomeDx Biosciences, Vancouver, British Columbia, Canada

  ⨯
• Elai Daviconi,

  Affiliation GenomeDx Biosciences, Vancouver, British Columbia, Canada

  ⨯
• R. Jeffrey Karnes,

  Affiliation Department of Urology, Mayo Clinic, Rochester, MN, United States of America

  ⨯
• Robert B. Jenkins,

  Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States of America

  ⨯
• Nirav Patel,

  Affiliation Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, VA, United States of America

  ⨯
• Robert B. Den,

  Affiliation Department of Radiation Oncology, Jefferson Medical College and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States of America

  ⨯
• Timothy N. Showalter

  Affiliation Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, VA, United States of America

  ⨯